Salving the Needs of Sick Asians and Profiting From It

IHH Healthcare Berhad MD Dr. Lim Cheok Peng discusses:     IPO:   - Cornerstone investors - bought 58 per cent of your IPO - merits to their financial stability and prestige - sheer number - 22 - a record - Why so many;   - Lockup period - issues;   - Minuscule allocation for retail portion - criticism - issues;     BUSINESS:   - Scale - merits - demerits;   - And at an issue price of 2.80 ringgit, IHH debuted at a valuation of 93 times PE, similar to Facebook - issues;   - Growth assumptions - issues;   - Already paying about 75% of the capital expenditures for new beds - impact on earnings;   - Turkey (37.5%), Singapore (36.9%) and Malaysia (21.5%) comprise the biggest revenue contributions (95.9% of revenue) - extent to which this mix is malleable -- whether SG and Turkey will remain as main;   - In SG, trending towards single-bed wards -- whether regulatory - issues;   - Dependence on private practitioners to develop practise within premises for Malaysian and Singaporean operations - issues;   - Competition - Connexion One & Raffles Medical in Singapore - Singapore Healthcare 2020 Masterplan;   - 42 per cent costs are on staff: specifically, doctors -- availability and affordability - key and potential limitations;   - Suitable and qualified nurses, ancillary help - issues;   - Latest results announcement - underlying growth - issues;   - Dividends - issues;     M&A  - Whether plan to increase to 100 per cent, stakes in Turkish Acibadem Group from 60 per cent now;   - And what of associate stakes in Apollo in India;   - Acquisitions - MY - CH.